Hôpital Riviera-Chablais-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2018

  1. Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer

    British Journal of Cancer, Vol. 119, Núm. 10, pp. 1208-1214